abstract |
The present invention provides a novel compound useful for the treatment of GSK-related diseases, which inhibits GSK3 (glycogen synthase kinase 3). A compound represented by the following formula is provided. □ [wherein, R1, R2, R3, R4, X1, and X2 are each synonymous with the definition in the specification. A compound represented by the formula or a salt thereof. |